Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Harvard Business School
Covington
Moodys
Queensland Health
Daiichi Sankyo
Argus Health
Chinese Patent Office
Citi

Generated: April 25, 2018

DrugPatentWatch Database Preview

Details for Patent: 4,915,950

« Back to Dashboard

Summary for Patent: 4,915,950
Title: Printed transdermal drug delivery device
Abstract:A method for making transdermal drug delivery devices is provided which includes: laminating an adsorbent source layer to a pressure-sensitive, pharmaceutically acceptable contact adhesive; depositing a drug in liquid form on one face of the source layer; laminating an anchor adhesive layer to the opposing face of the source layer; and applying a drug-impermeable backing layer to the anchor adhesive, which backing layer then defines the upper surface of the device. The invention also encompasses transdermal drug delivery devices having a source layer in contact with and contained between anchor and contact adhesive layers, with a backing layer adjacent the anchor adhesive defining the upper surface of the device.
Inventor(s): Miranda; Jesus (Menlo Park, CA), Cleary; Gary W. (San Mateo, CA)
Assignee: Cygnus Research Corporation (Redwood City, CA)
Application Number:07/215,074
Patent Claim Types:
see list of patent claims
Use; Delivery; Device;

Drugs Protected by US Patent 4,915,950

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 4,915,950

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Germany 68924157 ➤ Try a Free Trial
Denmark 191890 ➤ Try a Free Trial
European Patent Office 0400078 ➤ Try a Free Trial
Spain 2011416 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
Moodys
Dow
Baxter
Boehringer Ingelheim
Julphar
Medtronic
Covington
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.